Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Short-term Investments (2021 - 2025)

Historic Short-term Investments for AVITA Medical (AVHHL) over the last 5 years, with Q4 2025 value amounting to $7.9 million.

  • AVITA Medical's Short-term Investments fell 6362.72% to $7.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.9 million, marking a year-over-year decrease of 6362.72%. This contributed to the annual value of $7.9 million for FY2025, which is 6362.72% down from last year.
  • As of Q4 2025, AVITA Medical's Short-term Investments stood at $7.9 million, which was down 6362.72% from $7.9 million recorded in Q3 2025.
  • AVITA Medical's 5-year Short-term Investments high stood at $66.9 million for Q4 2023, and its period low was $3.5 million during Q2 2025.
  • For the 5-year period, AVITA Medical's Short-term Investments averaged around $33.7 million, with its median value being $29.7 million (2021).
  • In the last 5 years, AVITA Medical's Short-term Investments skyrocketed by 17813.04% in 2024 and then tumbled by 9050.92% in 2025.
  • Over the past 5 years, AVITA Medical's Short-term Investments (Quarter) stood at $29.6 million in 2021, then surged by 106.34% to $61.2 million in 2022, then grew by 9.42% to $66.9 million in 2023, then crashed by 67.38% to $21.8 million in 2024, then crashed by 63.63% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q4 2025, $7.9 million for Q3 2025, and $3.5 million during Q2 2025.